Unknown

Dataset Information

0

The RNA binding protein MEX3A promotes tumor progression of breast cancer by post-transcriptional regulation of IGFBP4.


ABSTRACT:

Purpose

Breast cancer (BC) is the most frequent malignant tumor in women worldwide with exceptionally high morbidity. The RNA-binding protein MEX3A plays a crucial role in genesis and progression of multiple cancers. We attempted to explore its clinicopathological and functional significance in BC in which MEX3A is expressed.

Methods

The expression of MEX3A detected by RT-qPCR and correlated the results with clinicopathological variables in 53 BC patients. MEX3A and IGFBP4 profile data of BC patients were downloaded from TCGA and GEO database. Kaplan-Meier (KM) analysis was used to estimate the survival rate of BC patients. Western Blot, CCK-8, EdU, colony formation and flow cytometry were performed to investigate the role of MEX3A and IGFBP4 in BC cell proliferation, invasion and cell cycle in vitro. A subcutaneous tumor mouse model was constructed to analyze in vivo growth of BC cells after MEX3A knockdown. The interactions among MEX3A and IGFBP4 were measured by RNA pull-down and RNA immunoprecipitation.

Results

The expression of MEX3A was upregulated in BC tissues compared to adjacent tissues and high expression of MEX3A was associated with poor prognosis. Subsequent in vitro studies demonstrated that MEX3A knockdown inhibited BC cells proliferation and migration, as well as xenograft tumor growth in vivo. The expression of IGFBP4 was significantly negatively correlated with MEX3A in BC tissues. Mechanistic investigation showed that MEX3A binds to IGFBP4 mRNA in BC cells, decreasing IGFBP4 mRNA levels, which further activated the PI3K/AKT and other downstream signaling pathways implicated cell cycle progression and cell migration.

Conclusion

Our results indicate that MEX3A plays a prominent oncogenic role in BC tumorigenesis and progression by targeting IGFBP4 mRNA and activating PI3K/AKT signaling, which can be used as a novel therapeutic target for BC.

SUBMITTER: Chen W 

PROVIDER: S-EPMC10460732 | biostudies-literature | 2023 Oct

REPOSITORIES: biostudies-literature

altmetric image

Publications

The RNA binding protein MEX3A promotes tumor progression of breast cancer by post-transcriptional regulation of IGFBP4.

Chen Wenhu W   Hu Liqiang L   Lu Xuemei X   Wang Xiaofei X   Zhao Changan C   Guo Chen C   Li Xiaoyan X   Ding Yuqin Y   Zhao Hongguang H   Tong Dongdong D   Wang Lifang L   Huang Chen C  

Breast cancer research and treatment 20230711 3


<h4>Purpose</h4>Breast cancer (BC) is the most frequent malignant tumor in women worldwide with exceptionally high morbidity. The RNA-binding protein MEX3A plays a crucial role in genesis and progression of multiple cancers. We attempted to explore its clinicopathological and functional significance in BC in which MEX3A is expressed.<h4>Methods</h4>The expression of MEX3A detected by RT-qPCR and correlated the results with clinicopathological variables in 53 BC patients. MEX3A and IGFBP4 profile  ...[more]

Similar Datasets

| S-EPMC9871011 | biostudies-literature
| S-EPMC10987644 | biostudies-literature
| S-EPMC6942431 | biostudies-literature
| S-EPMC6125628 | biostudies-literature
| S-EPMC8784817 | biostudies-literature
| S-EPMC6693420 | biostudies-literature
| S-EPMC3627580 | biostudies-literature
2023-01-08 | PXD038983 | Pride
| S-EPMC4872080 | biostudies-literature
| S-EPMC8728292 | biostudies-literature